Spots Global Cancer Trial Database for Stem Cell Transplant and Zoledronic Acid Improve Outcome in Previously Untreated Patients With Multiple Myeloma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Stem Cell Transplant and Zoledronic Acid Improve Outcome in Previously Untreated Patients With Multiple Myeloma
Official Title: Results of Phase III Study to Assess if Zoledronic Acid Have Antumor Activity in Multiple Myeloma
Study ID: NCT01234129
Conditions
Interventions
Study Description
Brief Summary: Assess the impact in outcome of the use of zoledronic acid in multiple myeloma.
Detailed Description: Assess if the use of zoledronic acid can improve outcome in patients with multiple myeloma whose are treated with cytoreductive therapy and stem cell transplant.
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Tertiary reference oncology center, Mexico, Distrito Federal, Mexico
Contact Details
Name: Agustin Aviles, MD
Affiliation: Instituto Mexicano del Seguro Social
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
